A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
National Institutes of Health Clinical Center (CC)
Pfizer
Centre Oscar Lambret
University of California, San Francisco
M.D. Anderson Cancer Center
Essen Biotech
Beth Israel Deaconess Medical Center
Merck Sharp & Dohme LLC
Takeda
Kidney Cancer Research Bureau
Second Life Therapeutics
NiKang Therapeutics, Inc.
Hadassah Medical Organization
Arsenal Biosciences, Inc.
A2 Biotherapeutics Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sensei Biotherapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
Memorial Sloan Kettering Cancer Center